Events

The New ICH M10 Guidelines A critical component of the regulatory decision regarding the efficacy and safety of therapeutic products is the bioanalytical concentration of therapeutic products in biological matrices. Therefore, it is imperative that the bioanalytical methods used are well characterized, validated, and documented to best support regulatory decisions. Explore the new ICH M10 […]

Celebrate Medicon Valley Alliance 25th year anniversary! The summer is approaching and the MVA Summer Reception is providing you with an excellent opportunity to meet with your network before you head off to your summer holiday, Members of Medicon Valley Alliance are invited to join us for the MVA Summer Reception, which will also mark […]

ReproUnion og Medicon Valley Alliance inviterer til ”TOPMØDE” med et stærkt panel der repræsenterer nationale, regionale og kommunale perspektiver. Debatten foregår i Det Fælles Sundhedstelt på Folkemødet hvorfra der også er live-streaming! Med afsæt i den faldende fertilitet i Danmark såvel som i store dele af verden omkring os, taler vi om demografi, fremtidens arbejdskraft […]

More so than any other core function of the biopharma industry, clinical trials have been buffeted by the prevailing winds of the pandemic. From the turbulent waves of infection causing overstretched healthcare facilities, inaccessible sites and patient availability through to the relative plain sailing of mammoth Phase III vaccine trials, COVID-19 has permanently changed the […]

Join HALOS Final Conference – a full-day event on the 8th of June. It will give you a chance to listen to e.g. presentations from HALOS researchers as well as discussions by stakeholders who will cover the results from HALOS and the future direction for the HALOS region. Everyone who wishes to present results from their HALOS projects in the […]

The Medicon Valley Alliance Microbiome Network, in collaboration with the Microbiome Signature Project, have the pleasure to invite you to a network meeting on 7 June 2022 in Copenhagen, focusing on rising stars in microbiome research. The network meeting will focus on some of the excellent research that is taking place in Medicon Valley within […]

Join the Microbiome Signature Project: Outcomes and Future Outlook event at Hubnordic in Ørestad, Copenhagen and learn more about recent investments and establishments in the region, meet international talent and for an exclusive presentation of a microbiome hub benchmarking study and a possible future microbiome platform for the Medicon Valley region. The Microbiome Signature Project: […]

– Hosted by Key2Compliance There are a large number of new start-ups in Medical Device and In Vitro Diagnostics in the Medicon Valley area. This seminar will focus on how a start-up in Medical Device or In Vitro Diagnostic can accelerate the development from idea to success within the current framework of regulations. Join us […]

En af EUs førende og største life science-klynger, dansk-svenske Medicon Valley, har udviklet sig til en vækst- og jobsucces. Der sker mange-milliardinvesteringer, som ventes at skabe fortsat vækst i Greater Copenhagen-regionen. Det fremgår af et mere end treårigt analysearbejde i projektet Greater Copenhagen Life Science Analyse Initiative, der drives i samarbejde mellem Medicon Valley Alliance […]

– Overcoming challenges when moving from non-clinical to clinical Going from non-clinical to clinical is no easy step. That’s why we’ve gathered a few of our key experts from essential product development areas to talk about how to survive and minimize the early risks biotech companies face during the life cycle of product development. Join […]

One World: How the Nordics and the international markets grow together and improve the quality of care   This year, MVA is celebrating it´s 25th year anniversary. The online-only days are fortunately over, and, consequently, we are excited to invite members of Medicon Valley Alliance Executive Club to the first 2022 MVA Executive Club Dinner […]

– Breaking through the current limitations Recombinant antibodies are highly specific detection probes in research, diagnostics, and have emerged over the last two decades as the fastest growing class of therapeutic proteins. Mammalian cell lines, especially the Chinese Hamster ovary (CHO) cell line, represent the most widely used expression systems for the production of these […]

Medicon Valley Alliance, together with member company Bioneer, have the pleasure to invite you to the Medicon Valley Alliance R&D Network meeting focusing on Biologics Development and Manufacturing on the 9th of May, 2022. Biologics have paved the way for new treatment paradigms. Dominated by protein and antibody therapeutics, the biologics market now accounts for […]

Connecting with and managing relationships with key opinion leaders (KOLs) is a crucial part of any research-based organization, as well as the surrounding ecosystem. Speaking with the right expert at the right time is invaluable. Breaking through the knowledge silos that exist within the life science industry is critical for any organization. However  finding, […]

Generalized Pairwise Comparison (GPC) is an innovative statistical method used to design and analyze clinical trials to make the best possible use of the data collected. This allows the analysis to take into account several endpoints, providing deeper insights into the net treatment benefits. Specifically, the GPC method enables you to: Assess clinical trials based […]

Members of Medicon Valley Alliance are invited to attend the Ordinary General Meeting 2022 Date: Wednesday April 6th, 2022 Time: 17.00-18.00 Venue: Online   Documents for the Ordinary General Meeting: Convening notice for the Ordinary General Meeting 2022 Medicon Valley Alliance Annual Report 2021 Power of Attorney  Ordinary General Meeting 2022 Bylaws   Registration […]

In collaboration with DiaUnion, DDA invites you to an exclusive day with the important topic “Biobank”. This day will provide you with insight and broaden your understanding on the multidisciplinary world of biobanking. The course aims to facilitate the participants with an interdisciplinary perspective on the historical, technical, legal, and ethical aspects, including the importance […]

Invitation is open to all members Medicon Valley Alliance, Symbion Community, and delegates at BIO-Europe Spring. As part of the Global Delegations Hub for partneringONE at BIO-Europe Spring 2022 we are glad to host a Live reception during BIO Spring 2022 here in Copenhagen. Main purpose is networking and an introduction to Copenhagen Capacity and […]

Medicon Valley Alliance together with member company Miltenyi Biotec have the pleasure to invite you to the 12th meeting of the Medicon Valley Alliance Oncology Network on the 16th of March, 2022. Immuno-oncology is sometimes referred to as the fifth pillar of cancer treatment, alongside surgery, radiotherapy, chemotherapy and precision therapy. The activation and utilization […]

Medicon Valley Alliance, together with Ideon Science Park and Sigma Connectivity, have the pleasure to invite you to the Medicon Valley Alliance Medtech Network meeting on 3rd of March, 2022 in Lund. Prototyping is an essential and fundamental part of medical device development and manufacturing. Not only is it critical for refining the design of […]

The pharmaceutical pipeline is gaining momentum, led by many first-time launchers. But the reality is companies spend >$200MM over three years leading up to launch, and 66% of drugs still don’t meet launch expectations. This looming risk, echoed by general industry pressures, leaves developers and investors alike looking for more advanced commercialisation options that effectively […]

Medicon Valley Alliance, together with Bacthera, have the pleasure to invite you to the Medicon Valley Alliance Microbiome Network meeting on 9th of February, 2022 in Copenhagen. Live biotherapeutic products (LBPs) are living microorganisms administered therapeutically and the human microbiome is an increasingly important avenue of health research. Today, we know that the microbiome plays […]

One of the major recent trends in drug development in oncology, particularly with highly targeted therapy and immunotherapy, is a great concern with efficacy assessment in early phases of development. This was not frequent before the era of precision medicine. As a result, phase 1 trials now routinely have efficacy endpoints and even sample-size justification […]

HALOS and Medicon Valley Alliance invite you to join us for a half-day symposium on how to benefit from using the large-scale research infrastructures such as MAX IV and ESS, and how the unique resources available in the Öresund-Hamburg area could be utilised in life science. During the symposium we will focus on using or […]

 an international outlook and regional challenges  Hologic Global Womens Health Index is a unique survey based on 120 000+ interviews representing 2.5 billion women and girls. Using the index as a starting point, we discuss possible ways forward for Swedish and Danish womens health – with a focus on cancer prevention. How can we mitigate the impact […]